Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Want (Dublin, United States of America). Role of angiotensin receptors in the preclinical cardiovascular risk in obstructive sleep apnea patients. 368

Member's Comments

No comment yet.

Related content which might interest you: The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Source: Eur Respir J 2009; 33: 574-580 Year: 2009 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016 Year: 2017 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 The impact of obstructive sleep apnea syndrome on cardiovascular system in children Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms Source: Eur Respir J 2001; 17: 728-732 Year: 2001 Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010